INmune Bio
INMB
INMB
26 hedge funds and large institutions have $15M invested in INmune Bio in 2020 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 6 increasing their positions, 4 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
10% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 10
Holders
26
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$3.75M | |
| 2 | +$979K | |
| 3 | +$796K | |
| 4 |
BFM
Boothbay Fund Management
New York
|
+$399K |
| 5 |
DC
Diametric Capital
Boston,
Massachusetts
|
+$215K |
Top Sellers
| 1 | -$2.58M | |
| 2 | -$1.03M | |
| 3 | -$760K | |
| 4 |
Renaissance Technologies
New York
|
-$412K |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$247K |